Spinal Muscular Atrophy Market: Phase 3 Candidate ISIS-SMN Rx Shows Promising Results in Clinical Trial Transparency Market Research, in its latest...
What is spinal muscular atrophy and what is its tratment
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2015 Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2015 market research report is the lat...
Mobile Phone Accessories Market provides profiles of leading players in the market based on the following parameters company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and stra
Spinal Muscular Atrophy Market Analysis Detailed Profiles of Top Industry Players and Their Segments Till 2023 Spinal muscular atrophy (SMA) is a her...
Spinal Muscular Atrophy Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION Spinal Muscular Atrophy Market – Overview The global spinal muscular atrophy market size was valued at US$ 884 million in 2017 and is expected to witness a robust CAGR of 12.4% over the forecast period (2018–2026). Spinal muscular atrophy (SMA) is a genetic disorder that affects the control of muscle movement. It is caused due to loss of specialized nerve cells, called motor neurons, in the spinal cord and brainstem. The loss of motor neurons leads to weakness and atrophy of muscles used for activities such as sitting up, walking, crawling, and controlling head movement. In severe cases, the muscles used for swallowing and breathing are also affected. There are four types of spinal muscular atrophy, which are differentiated based on the severity of muscle weakness, pattern of features, and age, when the muscle problems begin. These are classified as type 1, 2, and 3 that appears in childhood. Type 4 appears in adulthood and is also termed as adult onset SMA.
REPORT DESCRIPTION Spinal Muscular Atrophy Market Dynamics: Major factors driving growth of the spinal muscular atrophy market includes increasing number of clinical trials and rising government support for R&D. Biotechnology and biopharmaceutical companies are working towards development of effective therapies to treat spinal muscular atrophy. For instance, in 2016, the U.S. FDA approved Spinraza (nusinersen) drug from Biogen for the treatment of SMA. Spinraza targets the underlying defect in SMA, so it can help prevent, delay, or even reverse the symptoms. However, its common side effects include higher risk of constipation and respiratory tract infection along with minimal risk of kidney problems and bleeding. Moreover, the cost of research for development of new therapy is also high. With the advancements of drug in the pipeline, its expense and time for development also increases. According to Cure SMA, it can take over 15 years and US$ 100 million for a single drug candidate to reach FDA approval. These factors make research challenging particularly for a disease such as SMA. These factors are expected to hinder growth of the market. Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1920
Biogen Cytokinetics, Inc. F. Hoffmann-La Roche Novartis AG Pfizer Inc. Ionis Pharmaceuticals, Inc
Read More @ https://www.coherentmarketinsights.com/market-insight/spinal-muscular-atrophy-market-1920
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an ofce at the global fnancial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We ofer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES
MARKET INTELLIGENCE SERVICES
COUNTRY SPECIFIC STUDIES
ABOUT CMI SECTOR COVERAGE
Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies Universities and Business Schools.
ABOUT US KEY STATS
100 + 150+
Insights Published Per Year
Consulting Projects Till Date
Clients Worldwide Per Year
CONSUL T PROJECT S
COUNT RY ANALYS IS SURVEY RESEAR CH
EXCEL FORECAST DATABASE
TECHNOLOG Y SNIPPETS
COMPETITIV E ASSESSMEN T
Analysts and Contract Consultants
Coherent Market Insights excels at ofering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702